NYSE:CDAYCeridian HCM Stock Price, Forecast & News

Ceridian HCM's stock was trading at $56.63 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CDAY stock has decreased by 21.5% and is now trading at $44.47. View which stocks have been mosted impacted by Coronavirus.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ceridian HCM in the last year. There are currently 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Ceridian HCM.

Ceridian HCM is scheduled to release its next quarterly earnings announcement on Wednesday, May 6th 2020. View our earnings forecast for Ceridian HCM.

Ceridian HCM Holding Inc (NYSE:CDAY) posted its quarterly earnings results on Wednesday, February, 5th. The company reported $0.08 earnings per share for the quarter, topping analysts' consensus estimates of $0.07 by $0.01. The business had revenue of $221.80 million for the quarter, compared to analyst estimates of $221.15 million. Ceridian HCM had a net margin of 9.55% and a return on equity of 1.73%. The business's revenue was up 10.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.07 earnings per share. View Ceridian HCM's earnings history.

Ceridian HCM updated its FY 2020 After-Hours earnings guidance on Wednesday, February, 5th. The company provided EPS guidance of for the period. The company issued revenue guidance of $903-908 million, compared to the consensus revenue estimate of $929.78 million.

16 Wall Street analysts have issued 1-year target prices for Ceridian HCM's stock. Their forecasts range from $51.00 to $87.00. On average, they expect Ceridian HCM's stock price to reach $69.50 in the next twelve months. This suggests a possible upside of 56.3% from the stock's current price. View analysts' price targets for Ceridian HCM.

News coverage about CDAY stock has trended very negative this week, according to InfoTrie. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Ceridian HCM earned a daily sentiment score of -3.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutCeridian HCM.

Ceridian HCM saw a increase in short interest in the month of February. As of February 28th, there was short interest totaling 9,570,000 shares, an increase of 18.0% from the February 13th total of 8,110,000 shares. Based on an average daily trading volume, of 1,180,000 shares, the short-interest ratio is presently 8.1 days. Currently, 8.3% of the shares of the company are short sold. View Ceridian HCM's Current Options Chain.

Some companies that are related to Ceridian HCM include Veeva Systems (VEEV), Square (SQ), ANSYS (ANSS), Synopsys (SNPS), Cadence Design Systems (CDNS), Citrix Systems (CTXS), Splunk (SPLK), Atlassian (TEAM), Check Point Software Technologies (CHKP), Tableau Software (DATA), Okta (OKTA), Docusign (DOCU), TAKE-TWO INTERACTIVE SOFTWARE (TTWO), Crowdstrike (CRWD) and Twilio (TWLO).

Based on aggregate information from My MarketBeat watchlists, some companies that other Ceridian HCM investors own include Workday (WDAY), Alibaba Group (BABA), NVIDIA (NVDA), Costco Wholesale (COST), Tesla (TSLA), Adobe (ADBE), Advanced Micro Devices (AMD), Wynn Resorts (WYNN), Alteryx (AYX) and Twilio (TWLO).

(CDAY) raised $420 million in an initial public offering (IPO) on Thursday, April 26th 2018. The company issued 21,000,000 shares at a price of $19.00-$21.00 per share. Goldman Sachs, J.P. Morgan, Credit Suisse and Deutsche Bank Securities acted as the underwriters for the IPO and Barclays, Citigroup, Jefferies, CIBC Capital Markets, Wells Fargo Securities, Baird, Canaccord Genuity, Piper Jaffray, William Blair and MUFG were co-managers.

Ceridian HCM trades on the New York Stock Exchange (NYSE) under the ticker symbol "CDAY."

Ceridian HCM's stock is owned by a number of retail and institutional investors. Top institutional investors include State of Alaska Department of Revenue (0.01%) and Nelson Van Denburg & Campbell Wealth Management Group LLC (0.00%). Company insiders that own Ceridian HCM stock include Arthur Gitajn, Cannae Holdings, Inc, David D Ossip, Lisa M Sterling, Ozzie J Goldschmied, Paul D Elliott, Scott A Kitching and Thomas H Lee Advisors, Llc. View institutional ownership trends for Ceridian HCM.

CDAY stock was sold by a variety of institutional investors in the last quarter, including Nelson Van Denburg & Campbell Wealth Management Group LLC. Company insiders that have sold Ceridian HCM company stock in the last year include Arthur Gitajn, Cannae Holdings, Inc, David D Ossip, Lisa M Sterling, Ozzie J Goldschmied, Scott A Kitching, and Thomas H Lee Advisors, Llc. View insider buying and selling activity for Ceridian HCM.

CDAY stock was purchased by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. View insider buying and selling activity for Ceridian HCM.

Shares of CDAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CDAY stock can currently be purchased for approximately $44.47.

Ceridian HCM has a market capitalization of $6.34 billion and generates $824.10 million in revenue each year. The company earns $78.70 million in net income (profit) each year or $0.26 on an earnings per share basis. Ceridian HCM employs 5,011 workers across the globe. View additional information about Ceridian HCM.

The official website for Ceridian HCM is http://www.ceridian.com/.

Ceridian HCM's mailing address is 3311 EAST OLD SHAKOPEE ROAD, MINNEAPOLIS MN, 55425. The company can be reached via phone at 952-853-8100 or via email at [email protected]